Alberto Quattrocchi

Pubblicazioni

Titolo Pubblicato in Anno
Nuclear miR-223 affects chromatin organization and regulates Flotillin-1 gene expression in myeloid progenitors MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2024
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target ASPECTS OF MOLECULAR MEDICINE 2023
The epigenetic/transcriptional activity of nuclear mir-223 regulates flotillin-1 expression and function in myeloid differentiation 1st Epigenetics Society International Meeting “Epigenetics of Disease and Development” 2023
The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation HAEMATOLOGICA 2022
Thalassemias. From gene to therapy MOLECULAR ASPECTS OF MEDICINE 2021
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera AMERICAN JOURNAL OF HEMATOLOGY 2020
Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models SCIENTIFIC REPORTS 2019
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro HEMASPHERE 2018
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera HEMASPHERE 2018
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis. HAEMATOLOGICA 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma